Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alterations of the Human Gut Microbiome in Chronic Kidney Disease
Zhigang Ren, Yajuan Fan, Ang Li, et al.
Advanced Science (2020) Vol. 7, Iss. 20
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy
Lili Zhang, Zhisheng Wang, Xiaona Zhang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 79
Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy
Jin Zhao, Ming Bai, Xiaoxuan Ning, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 12, pp. 2276-2292
Open Access | Times Cited: 75
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 70
Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats
Li Cheng, Xulong Chen, Jingchun Yao, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314029-e0314029
Open Access | Times Cited: 2
Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, et al.
iMeta (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review
Jin Zhao, Xiaoxuan Ning, Baojian Liu, et al.
Renal Failure (2021) Vol. 43, Iss. 1, pp. 102-112
Open Access | Times Cited: 94
The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
Yinghui Huang, Wang Xin, Jiachuan Xiong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential
Hubert Krukowski, Sophie Valkenburg, Avra-Melina Madella, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 2, pp. 87-101
Closed Access | Times Cited: 45
Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes—A Systematic Review
Luminița Voroneanu, Alexandru Burlacu, Crischentian Brinza, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1948-1948
Open Access | Times Cited: 31
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 27
Exploring the Preventive and Therapeutic Mechanisms of Probiotics in Chronic Kidney Disease through the Gut–Kidney Axis
Hsiao-Wen Huang, Ming‐Ju Chen
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 15, pp. 8347-8364
Open Access | Times Cited: 11
Microbiome interactions with different risk factors in development of myocardial infarction
Manisha Bijla, Sunil Saini, Ajai Kumar Pathak, et al.
Experimental Gerontology (2024) Vol. 189, pp. 112409-112409
Open Access | Times Cited: 10
A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects
Paulina Mertowska, Sebastian Mertowski, Julia Wojnicka, et al.
Nutrients (2021) Vol. 13, Iss. 10, pp. 3637-3637
Open Access | Times Cited: 46
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
Qing Zhang, Yanmei Zhang, Lu Zeng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 46
Biomarker‐Responsive Nanosystems for Chronic Disease Theranostics
Qinrui Fu, Leilei Yu, Yin Wang, et al.
Advanced Functional Materials (2022) Vol. 33, Iss. 2
Closed Access | Times Cited: 32
Alterations of nasal microbiome in eosinophilic chronic rhinosinusitis
Yibo Liang, Runxiang Xie, Xin Xiong, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 5, pp. 1286-1295.e2
Closed Access | Times Cited: 17
Association of the gut microbiome with kidney function and damage in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Brandilyn A. Peters, Qibin Qi, Mykhaylo Usyk, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease
Pan Zhang, Xifan Wang, Shenghui Li, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 17
Longitudinal Pilot Evaluation of the Gut Microbiota Comparing Patients With and Without Chronic Kidney Disease
Shirin Pourafshar, Binu Sharma, Jenifer Allen, et al.
Journal of Renal Nutrition (2024) Vol. 34, Iss. 4, pp. 302-312
Closed Access | Times Cited: 6
Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging
Md Jamal Uddin, Mithila Farjana, Akhi Moni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8258-8258
Open Access | Times Cited: 37
Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives
Panagiotis Theofilis, Aikaterini Vordoni, Maria Koukoulaki, et al.
American Journal of Nephrology (2021) Vol. 52, Iss. 9, pp. 693-701
Open Access | Times Cited: 37
Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota
Suxian Lin, Tao Zhang, Lingxiao Zhu, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 9, pp. 781-791
Closed Access | Times Cited: 35
Potential Associations Between Microbiome and COVID-19
Huifen Wang, Haiyu Wang, Ying Sun, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 34
The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure—the current facts and evidence
Arun Prasath Lakshmanan, Selvasankar Murugesan, Souhaila Al Khodor, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top